Chromosomal Deletion in 7q31.2-31.32 Involving Ca2+-Dependent Activator Protein for Secretion Gene in a Patient with Cerebellar Ataxia: a Case Report by 조성래 & 홍승빈
HIGHLIGHTS
• We present a patient with cerebellar ataxia who has chromosomal deletion.
• This is the first report of chromosomal deletion in 7q31.2-31.32 including CADPS.
• Functional level was improved through balance training with a dopamine agonist.
Received: Sep 14, 2019
Revised: Nov 12, 2019
Accepted: Nov 20, 2019
Correspondence to
Sung-Rae Cho
Department of Rehabilitation Medicine, Yonsei 
University College of Medicine, 50-1 Yonsei-ro, 
Seodaemun-gu, Seoul 03722, Korea.
E-mail: srcho918@yuhs.ac
Seungbeen Hong, Su Ji Lee, Sung-Rae Cho
Brain & NeuroRehabilitation
02
iCopyright © 2020. Korean Society for Neurorehabilitation
Case Report
Brain Neurorehabil. 2020 Mar;13(1):e9
https://doi.org/10.12786/bn.2020.13.e9
pISSN 1976-8753·eISSN 2383-9910
Chromosomal Deletion in 7q31.2-31.32 
Involving Ca2+-Dependent Activator 
Protein for Secretion Gene in a Patient 
with Cerebellar Ataxia: a Case Report
1/7
ABSTRACT
We present a 33-year-old male patient with cerebellar ataxia. He was first considered to have 
a psychiatric conversion disorder but finally found to have chromosomal deletion in 7q31.2-
31.32 involving Ca2+-dependent activator protein for secretion (CADPS) gene. When a targeted gene 
sequencing using next-generation sequencing panel and chromosomal microarray analysis 
were performed, an 8.6 Mb deletion within chromosome 7q31.2-31.32 was discovered. 
Deletion of CADPS gene in the 7q31.2-31.32 was suggested as the causative factor of cerebellar 
ataxia. Functional levels evaluated by Berg balance scale and modified Barthel index were 
improved via comprehensive rehabilitation including balance training and a dopamine 
agonist medication. To the best of our knowledge, this is the first report of chromosomal 
deletion in 7q31.2-31.32 including CADPS gene detected in patients with cerebellar ataxia.
Keywords: Cerebellar Ataxia; Chromosome Disorders; Ca2+-Dependent Activator Protein for 
Secretion, Human
INTRODUCTION
Cerebellar ataxia is characterized by impaired balance and coordination caused by cerebellar 
dysfunction [1]. In general, dysmetria, limb ataxia, dysdiadochokinesis, or intention tremor 
are observed during physical examination. Cerebellar ataxia has a heterogeneous etiology 
and manifests as either acute or chronic forms. The most common causes of acute cerebellar 
ataxia include vascular disorders such as ischemia or hemorrhage, toxins, and medications. 
Chronic progressive ataxia is the most common form of hereditary cerebellar ataxia, although 
its rate of progression and severity vary depending on the causative gene.
Hereditary cerebellar ataxia usually has an autosomal pattern of inheritance, including 
spinocerebellar ataxia (SCA), Friedreich's ataxia, and ataxia-telangiectasia. SCAs are 
autosomal dominant ataxias classified as SCA1 through SCA36 according to the genetic 
loci [2]. Friedreich's ataxia is an autosomal recessive disorder and ataxia-telangiectasia is 
associated with defective DNA repair [3,4]. Although it is uncommon, de novo mutation in 
various genes related to cerebellar function can trigger cerebellar ataxia.
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Here, we present a 33-year-old male patient with cerebellar ataxia. He was initially considered 
to have a psychiatric conversion disorder without organic causes. However, a deletion in 
chromosome 7q31.2-31.32 including Ca2+-dependent activator protein for secretion (CADPS) gene 
was discovered by targeted gene sequencing using a next-generation sequencing (NGS) panel 
and chromosomal microarray. To the best of our knowledge, the role of this chromosomal 
deletion in 7q31.2-31.32 involving CADPS gene in a patient with cerebellar ataxia has never 
been reported.
CASE DESCRIPTION
A 33-year-old male visited the clinic of our hospital with complaints of weakness in bilateral 
lower extremities and balance problem. At first, he could walk independently until 2016 and 
perform daily living activities without assistance. For no particular reason, he recognized 
weaknesses in both lower extremities since January 2017 with slowly worsening symptoms. 
His symptoms showed chronic and progressive patterns. Several examinations including 
brain magnetic resonance imaging (MRI) and C-spine MRI performed at the Department 
of Neurology in other hospitals revealed no specific findings. When he was referred to our 
hospital in April 2017, he showed weakness in both legs along with poor standing balance, 
resulting in gait disturbance without hand support.
He was born without any complications. There was no notable family history. Although he 
started to walk at 20 months, he grew up within normal range. During his school days, he 
showed poor academic performance and was bullied by his class-mates. He had difficulties 
with getting along with his colleagues in the workplace. He has been on medication for 
depression and insomnia since October 2016.
Due to his psychiatric history and relatively mild neurological symptoms, the possibility of 
malingering or other psychiatric diseases was suspected. Thus, a psychological interview 
was conducted at other hospital to assess the relevance of motor weakness and psychological 
causes. The interview revealed significant distress associated with relationships with family 
members and colleagues. Thus, a diagnosis of conversion disorder was suggested.
Manual muscle test revealed grade 4 in bilateral lower extremities. No sensory impairment 
was detected. The patient presented with no signs of spasticity involving all four extremities. 
Dysmetria was marked in finger-to-nose and heel-to-shin test. A clumsy response was found 
in rapid alternating movement evaluation. Romberg sign and tandem gait were undetectable 
due to poor standing balance. The patient scored 26 points on the Berg balance scale. His 
activities of daily living were not independent because of weakness and balance problem. His 
modified Barthel index score was 78 points at initial evaluation (Table 1).
To determine the causes of his symptoms, we performed electrophysiological studies to 
evaluate nerve conduction and somatosensory evoked potentials. Results did not show 
any evidence of peripheral neuropathy or central conduction defect. Laboratory results for 
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Table 1. Changes in Berg balance scale and modified Barthel index in a patient with cerebellar ataxia
Initial 6 months 12 months 18 months
Berg balance scale 26 40 46 54
Modified Barthel index 78 86 92 91
anti-GM1 antibody, anti-GD1b antibody, and anti-myelin-associated glycoprotein antibody 
were all negative. Official findings of brain MRI and C-spine MRI were within normal limits. 
Since cerebellar ataxia was found in physical examinations, we decided to perform brain 
positron emission tomography-computed tomography (PET-CT) scan despite normal brain 
MRI findings, which revealed a decreased fluorodeoxyglucose (FDG) uptake in the anterior 
cerebellum (Fig. 1).
Because there was no vascular insult or trauma history to explain the patient's cerebellar 
dysfunction, we also performed targeted gene sequencing by using a NGS panel including 172 
target genes associated with neuropathy. Massively parallel sequencing was done using the 
MiSeq System (Illumina, Inc., San Diego, CA, USA). Quality control and sequence analysis 
were performed with the BaseSpace (Illumina, Inc.) and NextGENE (SoftGenetics, State 
College, PA, USA) software programs and cross-validated with our custom analysis pipeline. 
Although whole-exome sequencing was not used for analysis, targeted NGS panel showed 
chromosomal deletion at 7q31.2-31.32 and possible copy-number variation (Fig. 2).
To confirm the chromosomal deletion, we further conducted chromosomal microarray analysis 
and whole-chromosome fluorescence in situ hybridization (FISH). The FISH results using 
whole-chromosome probes showed a 7q deletion. Comparative genomic hybridization was 
performed with oligonucleotides (microarray) using the Affymetrix Cytoscan 750K and found 
a deletion of approximately 8.6 Mb in the ‘q’ arm of chromosome 7 involving 7q31.2-31.32 band 
(Fig. 3). Among the affected genes involving 7q31.2-31.32 band in the OMIM database, CADPS2 
is known to be associated with autism spectrum disorder and cerebellar development [5,6].
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Fig. 1. Brain MRI and PET-CT images in a patient with cerebellar ataxia. 
There was no remarkable finding in brain MRI images (A), although hypometabolism in the anterior cerebellum 
was noted (B, arrow). 
MRI, magnetic resonance imaging; PET-CT, positron emission tomography-computed tomography.
The patient was provided with balance training and progressive gait training. After 12 
months, Berg balance scale was improved from 26 to 46 and modified Barthel index was 
increased from 78 to 92 (Table 1). However, he could not walk independently without using 
an anterior walker at the time. We prescribed a trial with dopamine agonist, pramipexole, 
to determine its effectiveness for ataxia and trunk control. Six months after treatment with 
a dopamine agonist, the patient is able to walk without the need for a walker. The patient's 
Berg balance scale was improved again from 46 to 54 (Table 1).
DISCUSSION
The chief complaint of the patient was weakness of both legs. However, no specific lesion 
was detected using brain MRI or C-spine MRI. Cerebellar ataxia was detected during physical 
examination and cerebellar FDG uptake decreased in brain PET-CT scan. The related genetic 
abnormality was then confirmed. In the absence of relevant evidence based on conventional 
tests, it may be necessary to consider genetic studies.
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Fig. 2. Next-generation sequencing analysis in a patient with cerebellar ataxia. 
There was a suspected finding of chromosomal deletion in 7q31.2-31.32.
CADPS family is known to regulate secretion of neuropeptides including brain-derived 
neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) from dense-core vesicles [7]. The 
two members of CADPS family include CADPS1 and CADPS2. CADPS1 is located in 3p14.2 
and Speidel et al. [8] reported that CADPS1 is necessary for catecholamine loading in 
large dense-core vesicles. On the other hand, CADPS2 is located in 7q31.32 and it is found 
in the cerebellum. It plays a crucial role in cerebellar development by releasing BDNF 
and NT-3. Sadakata et al. [5] have reported that CADPS2-deficient mice show suppressed 
phosphorylation of Trk receptors in the cerebellum and impaired neuronal survival, 
lobulation, and synaptogenesis during cerebellar development. Thus, it is possible that 
CADPS2 deletion is associated with symptoms of cerebellar ataxia in this patient, considering 
the location of the gene mutation.
CADPS2 variants are known to be associated with autism spectrum disorders. Sadakata et al. 
[9] have reported that CADPS2-knockout mice show autistic-like behaviors. Aberrant CADPS2 
mRNA has been found in autistic patients. Grabowski el al. [6] have reported a patient 
diagnosed with autism spectrum disorders associated with recurrent psychotic syndrome and 
a deletion involving the 7q31-32 band at the CADPS2 gene locus.
Cerebellar ataxia is not directly related to autistic disorders. In a previous study, however, 
some of the autistic patients were found to manifest cerebellar abnormalities [10]. Although 
autism was not clearly diagnosed in this patient, it might be included in the spectrum of 
autistic behavior disorders based on Diagnostic and Statistical Manual of Mental Disorders, 
5th Edition, considering his challenges with social life, including school and workplace.
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Fig. 3. Chromosomal microarray analysis in a patient with cerebellar ataxia. 
There was a deletion of approximately 8.6 Mb in the ‘q’ arm of chromosome 7 involving 7q31.2-31.32 band.
This patient showed a significant functional improvement based on Berg balance scale and 
modified Barthel index after intensive and repetitive balance training with psychological 
support. He received medications including ginkgo biloba extract, norepinephrine-dopamine 
reuptake inhibitor (bupropion), and beta-blocker (propranolol). However, the medications 
were not effective to control his symptoms. Based on a report that autism symptoms were 
improved by administrating dopamine agonist in the CADPS2 knock-out mouse model [9], 
a dopamine agonist (pramipexole) was tried to control ataxic symptoms. After taking a 
dopamine agonist for 6 months, he could walk independently without using an anterior 
walker. A further study is needed to determine if dopamine agonist represents an alternative 
treatment of choice for cerebellar ataxia with CADPS gene deletion.
In conclusion, we present a 33-year-old male with cerebellar ataxia who was found to have 
chromosomal deletion in 7q31.2-31.32 involving CADPS gene. Considering that there is no 
reported case of cerebellar ataxia associated with CADPS2, it is important to consider various 
gene mutations as the possible etiological factors for ataxia after excluding the common causes.
REFERENCES
 1. Marquer A, Barbieri G, Pérennou D. The assessment and treatment of postural disorders in cerebellar 
ataxia: a systematic review. Ann Phys Rehabil Med 2014;57:67-78. 
PUBMED | CROSSREF
 2. Whaley NR, Fujioka S, Wszolek ZK. Autosomal dominant cerebellar ataxia type I: a review of the 
phenotypic and genotypic characteristics. Orphanet J Rare Dis 2011;6:33. 
PUBMED | CROSSREF
 3. Renaud M, Tranchant C, Martin JV, Mochel F, Synofzik M, van de Warrenburg B, Pandolfo M, Koenig 
M, Kolb SA, Anheim M, Alonso I, Azzedine H, Barbot C, Bereau M, Berkovic S, Bernard G, Bindoff LA, 
Bompaire F, Bonneau D, Bonneau P, Boycott KM, Bras J, Brais B, Brigatti KW, Cameron J, Chamova T, 
Choquet K, Delague V, Denizeau P, Dotti MT, El-Euch G, Elmalik SA, Federico A, Fiskerstrand T, Gagnon 
C, Guerreiro R, Guissart C, Hassin-Baer S, Heimdal KR, Héron B, Isohanni P, Kalaydijeva L, Kawarai T, 
Koht JA, Lai SC, Piana RL, Lecocq C, Linnankivi T, Lönnqvist T, Lu CS, Maas R, Mahlaoui N, Mallaret 
M, Marelli C, Mariotti C, Mathieu J, Méneret A, Mignarri A, Monin ML, Montaut S, Nanetti L, Nadjar Y, 
Poujois A, Salih MA, Sousa S, Stanier P, Stoppa-Lyonnet D, Strauss K, Tallaksen C, Tarnopolsky M, Tinant 
N, Tournev I, Topaloglu H, Varhaug KN, Woimant F, Wolf NI, Yahalom G, Yoon G, Young M; RADIAL 
Working Group. A recessive ataxia diagnosis algorithm for the next generation sequencing era. Ann 
Neurol 2017;82:892-899. 
PUBMED | CROSSREF
 4. Gatti RA, Berkel I, Boder E, Braedt G, Charmley P, Concannon P, Ersoy F, Foroud T, Jaspers NG, Lange K, 
Lathrop GM, Leppert M, Nakamura Y, O'Connell P, Paterson M, Salser W, Sanal O, Silver J, Sparkes RS, 
Susi E, Weeks DE, Wei S, White R, Yoder F. Localization of an ataxia-telangiectasia gene to chromosome 
11q22-23. Nature 1988;336:577-580. 
PUBMED | CROSSREF
 5. Sadakata T, Kakegawa W, Mizoguchi A, Washida M, Katoh-Semba R, Shutoh F, Okamoto T, Nakashima 
H, Kimura K, Tanaka M, Sekine Y, Itohara S, Yuzaki M, Nagao S, Furuichi T. Impaired cerebellar 
development and function in mice lacking CAPS2, a protein involved in neurotrophin release. J Neurosci 
2007;27:2472-2482. 
PUBMED | CROSSREF
 6. Grabowski PA, Bello AF, Rodrigues DL, Forbeci MJ, Motter V, Raskin S. Deletion involving the 7q31-32 
band at the CADPS2 gene locus in a patient with autism spectrum disorder and recurrent psychotic 
syndrome triggered by stress. Case Rep Psychiatry 2017;2017:4254152. 
PUBMED | CROSSREF
 7. Sadakata T, Mizoguchi A, Sato Y, Katoh-Semba R, Fukuda M, Mikoshiba K, Furuichi T. The secretory 




Deletion of CADPS Gene in Cerebellar Ataxia Brain & NeuroRehabilitation
02
https://e-bnr.org
 8. Speidel D, Bruederle CE, Enk C, Voets T, Varoqueaux F, Reim K, Becherer U, Fornai F, Ruggieri S, 
Holighaus Y, Weihe E, Bruns D, Brose N, Rettig J. CAPS1 regulates catecholamine loading of large dense-
core vesicles. Neuron 2005;46:75-88. 
PUBMED | CROSSREF
 9. Sadakata T, Washida M, Iwayama Y, Shoji S, Sato Y, Ohkura T, Katoh-Semba R, Nakajima M, Sekine 
Y, Tanaka M, Nakamura K, Iwata Y, Tsuchiya KJ, Mori N, Detera-Wadleigh SD, Ichikawa H, Itohara 
S, Yoshikawa T, Furuichi T. Autistic-like phenotypes in Cadps2-knockout mice and aberrant CADPS2 
splicing in autistic patients. J Clin Invest 2007;117:931-943. 
PUBMED | CROSSREF
 10. Courchesne E, Yeung-Courchesne R, Press GA, Hesselink JR, Jernigan TL. Hypoplasia of cerebellar 
vermal lobules VI and VII in autism. N Engl J Med 1988;318:1349-1354. 
PUBMED | CROSSREF
7/7https://doi.org/10.12786/bn.2020.13.e9
Deletion of CADPS Gene in Cerebellar Ataxia Brain & NeuroRehabilitation
02
https://e-bnr.org
